Professor Sir Michael Rawlins stated in his oral evidence that Dr Galbraith's May 1983 letter and paper should have been provided to the CSM(B).
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Regulation of Commercial Factor Concentrates
Key Person(s)
Dr Nicol Spence Galbraith